UB Paderborn / Katalog / Suche / in CDI

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Arthritis care & research (2010), 2012-05, Vol.64 (5), p.625-639

2012

Volltextzugriff (PDF)

Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus

Annals of the rheumatic diseases, 2012-11, Vol.71 (11), p.1855-1860

2012

Volltextzugriff (PDF)

Achieving Consensus on Total Joint Replacement Trial Outcome Reporting Using the OMERACT Filter: Endorsement of the Final Core Domain Set for Total Hip and Total Knee Replacement Trials for Endstage Arthritis

Journal of rheumatology, 2017-11, Vol.44 (11), p.1723-1726

2017

Volltextzugriff (PDF)

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary

Journal of rheumatology, 2015-11, Vol.42 (11), p.2185-2189

2015

Volltextzugriff (PDF)

Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report

Journal of rheumatology, 2017-10, Vol.44 (10), p.1536-1543

2017

Volltextzugriff (PDF)

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop

Journal of rheumatology, 2014-04, Vol.41 (4), p.799-809

2014

Volltextzugriff (PDF)

Updating the OMERACT filter: implications for patient-reported outcomes

Journal of rheumatology, 2014-05, Vol.41 (5), p.1011-1015

2014

Volltextzugriff (PDF)

Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials

Journal of rheumatology, 2019-09, Vol.46 (9), p.1173-1178

2019

Volltextzugriff (PDF)

Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group

Journal of rheumatology, 2017-12, Vol.44 (12), p.1916-1919

2017

Volltextzugriff (PDF)

Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group

Seminars in arthritis and rheumatism, 2021-06, Vol.51 (3), p.607-617

2021

Volltextzugriff (PDF)

Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group

Journal of rheumatology, 2017-12, Vol.44 (12), p.1904-1910

2017

Volltextzugriff (PDF)

An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group

Journal of rheumatology, 2017-11, Vol.44 (11), p.1734-1739

2017

Volltextzugriff (PDF)

More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions

Journal of rheumatology, 2015-11, Vol.42 (11), p.2182-2184

2015

Volltextzugriff (PDF)

Patient advocacy and arthritis: moving forward

Bulletin of the World Health Organization, 2004-02, Vol.82 (2), p.115-120

2004

Volltextzugriff (PDF)

Commentary: Challenging the patience of patients

BMJ. British medical journal (International ed.), 2005-07, Vol.331 (7508), p.107

Leong, Amye L

International edition, 2005

Volltextzugriff (PDF)

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis

Arthritis and rheumatism, 2008-06, Vol.59 (6), p.762-784

2008

Volltextzugriff (PDF)

Challenging the patience of patients

BMJ, 2005-07, Vol.331 (7508), p.107

Leong, Amye L

2005

Volltextzugriff (PDF)

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2016-01, Vol.68 (1), p.1-26

2016

Volltextzugriff (PDF)

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Arthritis care & research (2010), 2016-01, Vol.68 (1), p.1-25

2016

Volltextzugriff (PDF)

Patient-reported outcomes in RA care improve patient communication, decision-making, satisfaction and confidence: qualitative results

Rheumatology (Oxford, England), 2020-07, Vol.59 (7), p.1662-1670

2020

Volltextzugriff (PDF)

Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set

Seminars in arthritis and rheumatism, 2024-02, Vol.64, p.152343-152343, Article 152343

2024

Volltextzugriff (PDF)

Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative

Seminars in arthritis and rheumatism, 2021-10, Vol.51 (5), p.1113-1116

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus

Achieving Consensus on Total Joint Replacement Trial Outcome Reporting Using the OMERACT Filter: Endorsement of the Final Core Domain Set for Total Hip and Total Knee Replacement Trials for Endstage Arthritis

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary

Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop

Updating the OMERACT filter: implications for patient-reported outcomes

Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials

Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group

Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group

Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group

An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group

More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions

Patient advocacy and arthritis: moving forward

Commentary: Challenging the patience of patients

Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis

Individualized decision aid for diverse women with lupus nephritis

Challenging the patience of patients

2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Patient-reported outcomes in RA care improve patient communication, decision-making, satisfaction and confidence: qualitative results

Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set

Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative

Suchergebnisse filtern